Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimization of initial dose regimen of tacrolimus in paediatric lung transplant recipients based on Monte Carlo simulation.

Journal of clinical pharmacy and therapeutics - 1 Oct 2022

Wang Dong-Dong, Mei Yu-Qing, Yang Lan, Ding Ke-Wen, Xue Jun-Jie, Wang Xuan, He Su-Mei, Wei Qun-Li

Abstract excerpt

WHAT IS KNOWN AND OBJECTIVES: The initial tacrolimus dose regimen in paediatric lung transplant recipients is unknown. The present study optimized the initial tacrolimus dose regimen for paediatric lung transplant recipients. METHODS: This study was based on a published population pharmacokinetic model of tacrolimus in lung transplant recipients and used Monte Carlo simulations to recommend an initial dose...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytochrome P-450 CYP3A
Share to Immunosuppressive Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Kidney Transplantation

Share to Monte Carlo Method

Share to Tacrolimus

Share to Transplant Recipients

Share to Voriconazole

Source

Identifiers

PMID: 35716040
DOI: 10.1111/jcpt.13717

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Optimization of initial dose regimen of tacrolimus in paediatric lung transplant recipients based on Monte Carlo simulation.PMID 35716040Read ↗

Weight, CYP3A5 Genotype, and Voriconazole Co-administration Influence Tacrolimus Initial Dosage in Pediatric Lung Transplantation Recipients with Low Hematocrit based on a Simulation Model.Semantic proximity Read ↗

Predictive Capacity of Population Pharmacokinetic Models for the Tacrolimus Dose Requirements of Pediatric Solid Organ Transplant Recipients.Semantic proximity Read ↗

Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review.Semantic proximity Read ↗

Genotype Informed Bayesian Dosing of Tacrolimus in Paediatric Solid Organ Transplant IndividualsSemantic proximity Read ↗

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.Semantic proximity Read ↗

Genotype-Guided Model for Prediction of Tacrolimus Initial Dosing After Lung Transplantation.Semantic proximity Read ↗

Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogenetics.Semantic proximity Read ↗

Evaluating the evidence for genotype-informed Bayesian dosing of tacrolimus in children undergoing solid organ transplantation: A systematic literature review.Semantic proximity Read ↗

Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients.Semantic proximity Read ↗

Population pharmacokinetic characteristics of tacrolimus in Chinese Han lung transplant recipients and optimisation of dosing regimenSemantic proximity Read ↗

Frequency of CYP3A5 Genetic Polymorphisms and Tacrolimus Pharmacokinetics in Pediatric Liver TransplantationSemantic proximity Read ↗

A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.